COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation
The year 2020 will be carved in the history books—with the proliferation of COVID-19 over the globe and with frontline health workers and basic scientists worldwide diligently fighting to alleviate life-threatening symptoms and curb the spread of the disease. Behind the shocking prevalence of death...
Main Authors: | Jihang Yu, Edouard I. Azzam, Ashok B. Jadhav, Yi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2212 |
Similar Items
-
COVID-19 and low-dose radiation therapy
by: Neal E. Dunlap, et al.
Published: (2021-12-01) -
Low-Dose Radiation Therapy for COVID-19: A Systematic Review
by: Seyed Mohammad Javad Mortazavi, et al.
Published: (2021-09-01) -
Radiation Dose Reduction in Thorax CT
by: Gizem Gul Koc, et al.
Published: (2014-06-01) -
A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
by: Hongshan Ji, et al.
Published: (2022-07-01) -
Comparison of Hematological Parameters between Diagnostic Radiation Workers and Non-Radiation Workers
by: Mohammad Keshtkar, et al.
Published: (2022-08-01)